Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
08/2012
08/16/2012WO2012108840A1 A novel expression cassette for efficient surface display of antigenic proteins
08/16/2012WO2012107932A1 B cell clonal immunotoxin and use thereof
08/16/2012WO2012106759A1 Modified plant defensins useful as anti-pathogenic agents
08/16/2012WO2012087943A3 Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
08/16/2012WO2012068236A3 Novel fungal oxidoreductases
08/16/2012WO2012054580A3 Polyvalent chimeric ospc vaccinogen and diagnostic antigen
08/16/2012WO2012053828A3 Human interleukin-1 receptor antagonist - hybrid fc fusion protein
08/16/2012US20120208771 Synthetic cholesterylamine-linker derivatives for agent delivery into cells
08/16/2012US20120208770 Carcinoma Homing Peptide (CHP), Its Analogs, and Methods of Using
08/16/2012US20120208769 Chemokine-Mucin Fusions Linked to Glycosylphosphatidylinositol (GPI)-Anchors in Tissue Regeneration and as Tumour Immune Adjuvants
08/16/2012US20120208760 Thrombopoietic compounds
08/16/2012US20120208234 Protein having affinity for immunoglobulin, and immunoglobulin-binding affinity ligand
08/16/2012US20120207756 Modified Antibody Compositions, Methods of Making and Using Thereof
08/16/2012US20120207706 A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
08/16/2012CA2825951A1 Pesticidal nucleic acids and proteins and uses thereof
08/16/2012CA2825118A1 Modified plant defensins useful as anti-pathogenic agents
08/16/2012CA2824252A1 Improved immunotherapy
08/15/2012EP2486055A2 Human domain antibodies against components of the human insulin-like growth factor (igf) system
08/15/2012EP2153843B1 Compositions and methods for the diagnosis and treatment of tumor
08/15/2012CN1708510B Cell surface layer-binding protein and utilization thereof
08/15/2012CN102639561A Multivalent antibodies
08/15/2012CN102634530A Gene of high expression lysine
08/15/2012CN102633884A Bacillus thuringiensis vip1like1/vip2like1 gene combination and application thereof
08/15/2012CN102633883A Fusion protein efficiently combined with epidermal growth factor receptor (EGFR), herstatin 2 (HER2) and vascular endothelial growth factor (VEGF), coded sequence and application of fusion protein
08/15/2012CN102633882A Protein complex and application of protein complex in tumor diagnosis and/or prognosis evaluation
08/15/2012CN102153653B Fusion protein of tumor blood vessel targeted polypeptide and tissue factor and preparation method thereof
08/15/2012CN101891822B Fusion polypeptide use for preventing and treating senile dementia by brain barrier permeability
08/15/2012CN101481420B Heterozygous antibacterial peptide CA-MA and recombinant expression method thereof
08/14/2012US8242250 Nucleic acid molecule encoding a cystine knot polypeptide
08/14/2012US8241642 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
08/09/2012WO2012106670A2 Expandable liquid volume in an led bulb
08/09/2012WO2012105596A1 Method for fluorescent labeling of protein
08/09/2012WO2012104791A1 Fusion polypeptides and uses thereof
08/09/2012WO2012040323A8 Multimeric il-15 soluble fusion molecules and methods of making and using same
08/09/2012US20120202948 Monodisperse random coil proteins and bioconjugates thereof
08/09/2012US20120202739 Gdf3 antibodies and related methods
08/09/2012US20120202713 Constructs and libraries comprising antibody surrogate light chain sequences
08/09/2012US20120202233 Methods and uses of KSR kinase, and mutations thereof
08/09/2012US20120202222 Enzyme fragment complementation assays for monitoring the activation of the voltage-gated potassium ion channel herg
08/09/2012US20120201841 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
08/09/2012US20120201757 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide
08/09/2012CA2826420A1 Expandable liquid volume in an led bulb
08/08/2012EP2484378A1 Hepatitis c virus vaccine composition
08/08/2012EP2482843A1 Methods of improving vaccine immunogenicity
08/08/2012EP1913954B1 Use of the eda domain of fibronectin
08/08/2012EP1871880B1 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them
08/08/2012EP0837938B1 Use of mp52 or mp121 for treating and preventing diseases of the nervous system
08/08/2012CN101934076B Bivalent marking live attenuated vaccine of non-propagation genetic engineering for resisting classical swine fever and Japanese encephalitis and application
08/08/2012CN101260145B Technique for separating and purifying recombination human serum albumin and fusion protein thereof
08/08/2012CN101195822B High-endophilicity targeting amalgamation protein
08/07/2012US8236556 Method of modulating gene expression using an ecdysone receptor-based inducible gene expression system
08/07/2012CA2457414C Virus coat protein/receptor chimeras and methods of use
08/07/2012CA2429384C Concatameric immunoadhesion
08/07/2012CA2146895C Ctla4/cd28ig hybrid fusion proteins
08/02/2012WO2012058363A3 Recombinant envelope protein of human immunodeficiency virus (hiv) and vaccine containing the same
08/02/2012WO2012009648A3 Novel nitrate reductase fusion proteins and uses thereof
08/02/2012US20120196804 Glucagon analogs exhibiting physiological solubility and stability
08/02/2012US20120196803 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
08/02/2012US20120196760 Methods and compositions for identifying modulators of anti-tetherin activity to inhibit propagation of viruses
08/02/2012US20120196346 Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
08/02/2012US20120196328 Fusion protein mixture for inducing human pluripotent stem cell and preparation method there of
08/02/2012US20120196297 Mass tags for mass spectrometric analysis of immunoglobulins
08/02/2012US20120195962 Multiepitope Vaccine for Her2/Neu-Associated Cancers
08/02/2012US20120195926 Methods of improving vaccine immunogenicity
08/02/2012US20120195919 Hybrid and tandem expression of neisserial proteins
08/02/2012US20120195912 Cripto Blocking Antibodies and Uses Thereof
08/02/2012US20120195897 Human domain antibodies against components of the human insulin-like growth factor (igf) system
08/02/2012US20120195895 Fusion Protein of an Anti-CD20 Antibody Fab Fragment and Lidamycin, a Method for Preparing the Same, and the Use Thereof
08/02/2012US20120195893 TH1/TH2 polarizing vaccines
08/02/2012US20120195882 lipoparticle comprising a protein and methods of making and using the same
08/02/2012US20120195866 PKD Ligands and Polynucleotides Encoding PKD Ligands
08/02/2012DE19919121B4 Multimeres CMV-Antigen The multimeric CMV antigen
08/01/2012EP2480579A2 Methods of treating inflammation
08/01/2012EP1728864B1 Monoclonal antibodies specific for different epitopes of human gp39 and methods for their use in diagnosis and therapy
08/01/2012EP1581242B1 Compositions and methods for modifying toxic effects of proteinaceous compounds
08/01/2012EP1572862B1 Chimeric retinoid x receptors and their use in a novel ecdysone receptor-based inducible gene expression system
08/01/2012EP1333853B1 Growth factor complex
08/01/2012EP1328653B1 Highly expressible genes
08/01/2012CN102618575A Experimental technology for large scale production of recombinant human IGF1-Fc fusion protein with mammalian cells
08/01/2012CN102618567A pET15b-PEP-1-VP3 plasmids, construction method of the pET15b-PEP-1-VP3 plasmids, PEP-1-VP3 fusion protein and expression method of the PEP-1-VP3 fusion protein
08/01/2012CN102618565A Cytotoxic T lymphocyte-associated antigen-4, (CTLA-4) fusion protein and preparation method and application thereof
08/01/2012CN102617739A Novel method for preventing or treating M tuberculosis infection
08/01/2012CN102617738A Polypeptides, coding sequences, preparation method and use of recombinant fusion protein CD4-LINKER-DC-SIGN (CLD)
08/01/2012CN102614510A Yeast-based therapeutic for chronic hepatitis C infection
08/01/2012CN102614506A Recombinant HPV16L2 protein vaccine and preparation method thereof
08/01/2012CN101880328B Th multi-epitope gene and fusion protein of cryptosporidium parvum and application thereof
07/2012
07/31/2012US8232252 Immunoglobulin/bone morphogenic protein fusion for treatment and prevention of inflammatory disorders
07/31/2012CA2532913C Method for the purification of a non-immunoglobulin protein comprising an immunoglobulin-like (ig-like) domain
07/31/2012CA2411919C Immunization of dairy cattle with chimeric gapc protein against streptococcus infection
07/26/2012WO2012053823A3 Fusion protein having factor ix activity
07/26/2012WO2012050402A3 Cell-permeable recombinant parkin protein and a pharmaceutical composition for treating degenerative brain diseases containing the same
07/26/2012US20120192310 Novel Bacillus thuringiensis Gene With Lepidopteran Activity
07/26/2012US20120192296 Preparation of isolated agonist anti-edar monoclonal antibodies
07/26/2012US20120190828 Bifunctional polypeptides
07/26/2012US20120190823 Artificial entropic bristle domain sequences and their use in recombinant protein production
07/26/2012US20120190822 Artificial entropic bristle domain sequences and their use in recombinant protein production
07/26/2012US20120190819 Scaffold polypeptides for heterologous peptide display
07/26/2012US20120190629 Light-receiving channel rhodopsin having improved expression efficiency
07/26/2012US20120189628 Anti-il-tif antibodies and methods of using in inflammation
07/26/2012US20120189627 Semi-Synthetic GLP-1 Peptide-FC Fusion Constructs, Methods and Uses
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 295